Next health unicorn: loading. Invest in a new model of healthcare.
Why Math Biology is the next frontier for investment.
DMA® technology is a revolutionary, low-risk investment aligned with global healthcare trends. It fosters cross-disciplinary collaboration, offers a scalable and sustainable business model, and delivers real clinical, social, and industrial benefits. It’s poised to become the next healthcare unicorn.
Diagnostics of the future, today.
DMA® is an operational, non-invasive, and zero-waste technology that combines minimal risk with maximum effectiveness. Backed by real-world data, it represents a safe, innovative investment—fully aligned with the future of personalized medicine.
Meeting the demand for precision healthcare.
Delivers comprehensive metabolic profiles for more accurate diagnoses and targeted therapies.
Inclusive and sustainable.
Enables high-quality screening anywhere—ideal for underserved areas—promoting equity in access to care.
Scalable model with franchising potential.
Math Biology is ready for global expansion, with a business model designed for adoption in both developed and emerging markets.
Social and economic impact.
Reduces invasive testing and healthcare costs through earlier diagnoses, supporting the sustainability of public health systems.
Clinical and scientific innovation.
Opens new frontiers in research and medicine, accelerating the development of more effective treatments.
Industrial and commercial applications.
Drives the creation of new wellness devices and services, unlocking revenue streams for insurers and pharma alike.
Market-ready and integration-friendly.
Easily integrates with existing healthcare solutions, creating synergies and strategic partnership opportunities.
An integrated approach between biologists and clinicians.
DMA® enables a systemic view of the human body, improving the precision and quality of care.
Our Team & Founders
The minds behind Math Biology
Our team combines expertise from big pharma, the AI industry and academia, alongside a track record of entrepreneurial success, including seasoned managers and partners supported by a group of dynamic young researchers.
Biologist and researcher with many years of experience in various international pharmaceutical companies and deep knowledge of metabolic processes.
For over ten years, Giuseppe worked collecting data and designing protocols to identify the Metabolic profile of people suffering from various disorders. This crucial activity is a pillar of the Math Biology innovation.
Graduated from Polytechnic of Milano, has over 25 years of experience applying mathematical optimization / artificial intelligence systems to complex processes. Raffaele obtained the prestigious international recognition, in the context of the application of decision sciences, called Franz Edelman, promoted by the American association Informs. Entrepreneur and Founder of ACT Operations Research, an Innovative SME that developed software technologies in decision science. ACT Operations Research thank to an M&A operation, is now part of the Spindox Group, and Raffaele became an Equity Partner in the Group
A degree in statistics and has forged a brilliant career in finance, particularly with the Azimut Group. Passionate about Real Economy and Venture Capital. CEO of 2 SPVs and CFO of 2 Startups, he has extensive knowledge of institutional and private investors, specialized in investments and asset management.
Maria Cristina Caracciolo is a lawyer and works as legal consultant for industrial Companies. She obtained a Ph.D. in comparative and International Law. She is used to support the management of the Companies she collaborate with regarding not only legal issues but also strategic solution to be adopted. In her activity she drafts and reviews all the legal documentation of the Company, Contract of any type and Minutes.
Raffaele Cerulli is a full professor of Operations Research in the Department of Mathematics at the University of Salerno. Raffaele covers the position of Director of the Department of Mathematics at the University of Salerno and is a member of the scientific committee of UMI (Italian Mathematical Union). Raffaele is also a Board Member of the Italian Association for Operations Research (AIRO), covering the role of President of AIRO since January 2024.
Emanuele Carpanzano is Director of Research, Development and Knowledge Transfer at the University of Applied Sciences and Arts of Southern Switzerland. He managed numerous R&D initiatives at international, national and regional level, as well as industrial research and knowledge transfer projects. He is active in different federal and international associations and institutions dedicated to education, research and innovation programs and initiatives.
Francesca Antonella Aiello, PhD in Human Biology and Medical Genetics, specializes in scientific writing and research involving DMA technology, which is constantly updated to reflect the latest biomolecular knowledge of metabolic processes. Her expertise was developed during her PhD and post-doctoral work at leading research centers in Italy and abroad, focusing on specific diseases. As a registered Biologist, she applies and advances DMA to keep it aligned with current scientific advancements.
Maddalena Mazzali collaborates with organizations as a specialist in digital marketing, focusing on developing strategies that foster sustainable growth through effective communication design, strategic dissemination and engaging stakeholders. Within the intricate framework of making emerging technologies accessible to individuals, inclusivity stands at the core of Maddalena’s approach. By fostering understanding, she strives to make the world of innovation open and approachable, ensuring everyone can engage with and comprehend the transformative power of technology.
Our Partners
Together, we made it possible
Our incredible results were made possible thanks to the dedication of our partners, who have worked tirelessly alongside Math Biology over the past years.
UK Market Investor Network
Research Partner
GDPR & AI Compliance IT Security
Market & Business Analisys
BioSensor Research / Hardware
Research Partner
Notified Body
Software House
Medical Device Certification & ISO 13-485
Networking
Patents and Trademarks